Debashish Chowdhury DTCD MD (Medicine) DM (Neurology) FIAN FRCP (Edinburgh) Commonwealth Fellow in Stroke Medicine (Edinburgh)Director-Professor and Head, Department of Neurology, GB Pant Institute of Postgraduate Medical Education and Research, New Delhi, IndiaAtchayaram Nalini DM PhDProfessor, Neuromuscular Specialist, Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, IndiaVishnu VY MD DMAdditional Professor, Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India

• CHAPTER 1: Disease-modifying Therapies in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy: A Rapidly Changing ScenarioCHAPTER 2: Refractory Myasthenia: Management StrategiesCHAPTER 3: Congenital Myasthenic Syndromes: Genetic Spectrum and ManagementCHAPTER 4: Idiopathic Inflammatory Myopathies and Current ImmunologyCHAPTER 5: Updates on Limb–girdle Dystrophies and Gene TherapiesCHAPTER 6: Clinical Utility and Interpretation of Genetic Testing in Neuromuscular DisordersCHAPTER 7: Facioscapulohumeral Dystrophy: Update on TreatmentCHAPTER 8: Riboflavinopathies: Potentially Treatable DisordersCHAPTER 9: Mitochondrial Disorders: A Neuromuscular PerspectiveCHAPTER 10: Therapeutic Advances in NodoparanodopathiesCHAPTER 11: Chronic Inflammatory Demyelinating Polyradiculoneuropathy and its “Variants”: Current Treatment RecommendationsCHAPTER 12: Neuromuscular Imaging: MRI and UltrasoundCHAPTER 13: Hirayama Disease/Monomelic Amyotrophy: Recent Advances and Surgical ManagementCHAPTER 14: Recent Classification and Emerging Therapies in Charcot–Marie–Tooth DiseaseCHAPTER 15: Genetics of Amyotrophic Lateral Sclerosis and Implications for Therapy

Debashish Chowdhury DTCD MD (Medicine) DM (Neurology) FIAN FRCP (Edinburgh) Commonwealth Fellow in Stroke Medicine (Edinburgh)Director-Professor and Head, Department of Neurology, GB Pant Institute of Postgraduate Medical Education and Research, New Delhi, IndiaAtchayaram Nalini DM PhDProfessor, Neuromuscular Specialist, Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, IndiaVishnu VY MD DMAdditional Professor, Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India

• CHAPTER 1: Disease-modifying Therapies in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy: A Rapidly Changing ScenarioCHAPTER 2: Refractory Myasthenia: Management StrategiesCHAPTER 3: Congenital Myasthenic Syndromes: Genetic Spectrum and ManagementCHAPTER 4: Idiopathic Inflammatory Myopathies and Current ImmunologyCHAPTER 5: Updates on Limb–girdle Dystrophies and Gene TherapiesCHAPTER 6: Clinical Utility and Interpretation of Genetic Testing in Neuromuscular DisordersCHAPTER 7: Facioscapulohumeral Dystrophy: Update on TreatmentCHAPTER 8: Riboflavinopathies: Potentially Treatable DisordersCHAPTER 9: Mitochondrial Disorders: A Neuromuscular PerspectiveCHAPTER 10: Therapeutic Advances in NodoparanodopathiesCHAPTER 11: Chronic Inflammatory Demyelinating Polyradiculoneuropathy and its “Variants”: Current Treatment RecommendationsCHAPTER 12: Neuromuscular Imaging: MRI and UltrasoundCHAPTER 13: Hirayama Disease/Monomelic Amyotrophy: Recent Advances and Surgical ManagementCHAPTER 14: Recent Classification and Emerging Therapies in Charcot–Marie–Tooth DiseaseCHAPTER 15: Genetics of Amyotrophic Lateral Sclerosis and Implications for Therapy

Debashish Chowdhury DTCD MD (Medicine) DM (Neurology) FIAN FRCP (Edinburgh) Commonwealth Fellow in Stroke Medicine (Edinburgh)Director-Professor and Head, Department of Neurology, GB Pant Institute of Postgraduate Medical Education and Research, New Delhi, IndiaAtchayaram Nalini DM PhDProfessor, Neuromuscular Specialist, Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, IndiaVishnu VY MD DMAdditional Professor, Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India

• CHAPTER 1: Disease-modifying Therapies in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy: A Rapidly Changing ScenarioCHAPTER 2: Refractory Myasthenia: Management StrategiesCHAPTER 3: Congenital Myasthenic Syndromes: Genetic Spectrum and ManagementCHAPTER 4: Idiopathic Inflammatory Myopathies and Current ImmunologyCHAPTER 5: Updates on Limb–girdle Dystrophies and Gene TherapiesCHAPTER 6: Clinical Utility and Interpretation of Genetic Testing in Neuromuscular DisordersCHAPTER 7: Facioscapulohumeral Dystrophy: Update on TreatmentCHAPTER 8: Riboflavinopathies: Potentially Treatable DisordersCHAPTER 9: Mitochondrial Disorders: A Neuromuscular PerspectiveCHAPTER 10: Therapeutic Advances in NodoparanodopathiesCHAPTER 11: Chronic Inflammatory Demyelinating Polyradiculoneuropathy and its “Variants”: Current Treatment RecommendationsCHAPTER 12: Neuromuscular Imaging: MRI and UltrasoundCHAPTER 13: Hirayama Disease/Monomelic Amyotrophy: Recent Advances and Surgical ManagementCHAPTER 14: Recent Classification and Emerging Therapies in Charcot–Marie–Tooth DiseaseCHAPTER 15: Genetics of Amyotrophic Lateral Sclerosis and Implications for Therapy